Jiangsu Chinagreen Biological Technology Group Co.,Ltd. (SHE:300970)
China flag China · Delayed Price · Currency is CNY
17.82
-1.36 (-7.09%)
Aug 24, 2026, 4:00 PM EDT

SHE:300970 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
1,4871,2921,032996.22751.58578.08
Other Revenue
00--0.020
1,4871,2921,032996.22751.59578.09
Revenue Growth
39.24%25.17%3.60%32.55%30.01%-5.14%
Cost of Revenue
1,1551,084982.52870.12632.47539.94
Gross Profit
331.75207.7549.59126.1119.1238.15
Selling, General & Admin
77.2568.878.3780.1849.2937.25
Research & Development
20.3717.3714.6116.5314.048.62
Other Operating Expenses
-8.89-8.92-8.23-7.910.530.41
Operating Expenses
88.6577.1786.3589.3264.2946.72
Operating Income
243.1130.58-36.7636.7854.83-8.58
Interest Expense
-15.97-15.97-11.18-8.75-2.69-3.83
Interest & Investment Income
7.697.443.379.1816.716.21
Currency Exchange Gain (Loss)
-----0
Other Non Operating Income (Expenses)
7.18-0.19-0.341.8-0.39-0.2
EBT Excluding Unusual Items
242121.86-44.9139.0168.443.6
Gain (Loss) on Sale of Investments
----0.17-0.060.24
Gain (Loss) on Sale of Assets
-1.78-2.15-1.48-10.89-1.33-0.26
Asset Writedown
-8.45-0.67-0.4-3.57-0.36-
Other Unusual Items
0.260.262.51213.2913.21
Pretax Income
232.04119.31-44.2826.3779.9916.79
Income Tax Expense
0.010.050.1502.320.51
Earnings From Continuing Operations
232.03119.26-44.4226.3777.6716.28
Minority Interest in Earnings
-21.97-8.99-3.143.980.59-0.78
Net Income
210.06110.27-47.5730.3578.2515.5
Net Income to Common
210.06110.27-47.5730.3578.2515.5
Net Income Growth
----61.22%404.70%-88.30%
Shares Outstanding (Basic)
155154151152152144
Shares Outstanding (Diluted)
155154151152152144
Shares Change
2.26%2.21%-0.62%-0.06%5.46%8.65%
EPS (Basic)
1.350.72-0.320.200.520.11
EPS (Diluted)
1.350.72-0.320.200.520.11
EPS Growth
----61.20%378.55%-89.23%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
346.72222.19-130.42-57.48-228.07-121.01
Free Cash Flow Per Share
2.231.44-0.86-0.38-1.50-0.84
Dividend Per Share
0.3850.385-0.1540.154-
Dividend Growth
---0%-23.10%-
Gross Margin
22.31%16.08%4.81%12.66%15.85%6.60%
Operating Margin
16.35%10.11%-3.56%3.69%7.29%-1.48%
Profit Margin
14.12%8.54%-4.61%3.05%10.41%2.68%
Free Cash Flow Margin
23.31%17.20%-12.64%-5.77%-30.34%-20.93%
EBITDA
411.75295.88104.19154.31151.7975.92
EBITDA Margin
27.69%22.90%10.10%15.49%20.20%13.13%
D&A For EBITDA
168.65165.3140.95117.5396.9684.49
EBIT
243.1130.58-36.7636.7854.83-8.58
EBIT Margin
16.35%10.11%-3.56%3.69%7.29%-1.48%
Effective Tax Rate
0.00%0.04%--2.90%3.02%
Revenue as Reported
1,2921,2921,032996.22751.59578.09
Advertising Expenses
-0.140.450.260.030.89